LAUSR

Cytokine therapy, which activates the host immune system, has become an important and novel therapeutic approach to treat various cancers. Recent studies have shown that IL‐6 is an important cytokine that regulates the homeostasis in vivo. However, excessive IL‐6 plays a pathological role in a variety of acute and chronic inflammatory diseases, especially in cancer. IL‐6 can transmit signals through JAK/STAT, RAS /MAPK, PI3K/ Akt, NF‐κB, and other pathways to promote cancer progression. Phenolic compounds can effectively regulate the level of IL‐6 in tumor cells and improve the tumor microenvironment. This article focuses on the phenolic compounds through the regulation of IL‐6, participate in the prevention of cancer, inhibit the proliferation of cancer cells, reduce angiogenesis, improve therapeutic efficacy, and reduce side effects and other aspects. This will help to further advance research on cytokine therapy to reduce the burden of cancer and improve patient prognosis. However, current studies are mostly limited to animal and cellular experiments, and high‐quality clinical studies are needed to further determine their antitumor efficacy in humans.